120 related articles for article (PubMed ID: 29579855)
21. Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology.
Zuckerman R; Asif A; Costanzo EJ; Vachharajani T
J Bras Nefrol; 2018; 40(1):77-81. PubMed ID: 29796581
[TBL] [Abstract][Full Text] [Related]
22. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
[TBL] [Abstract][Full Text] [Related]
23. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis.
Legendre CM; Campistol JM; Feldkamp T; Remuzzi G; Kincaid JF; Lommelé Å; Wang J; Weekers LE; Sheerin NS
Transpl Int; 2017 Dec; 30(12):1275-1283. PubMed ID: 28801959
[TBL] [Abstract][Full Text] [Related]
25. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.
Chan MR; Thomas CP; Torrealba JR; Djamali A; Fernandez LA; Nishimura CJ; Smith RJ; Samaniego MD
Am J Kidney Dis; 2009 Feb; 53(2):321-6. PubMed ID: 18805611
[TBL] [Abstract][Full Text] [Related]
26. Outcome of kidney transplants for adults with hemolytic uremic syndrome in the U.S.: a ten-year database analysis.
Santos AH; Casey MJ; Wen X; Zendejas I; Faldu C; Rehman S; Andreoni KA
Ann Transplant; 2014 Jul; 19():353-61. PubMed ID: 25042028
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of hemolytic-uremic syndrome following live related renal transplantation.
Taheri D; Seyrafian S; Talebi A; Solez K
Arch Iran Med; 2006 Apr; 9(2):170-2. PubMed ID: 16649365
[TBL] [Abstract][Full Text] [Related]
28. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
Asif A; Nayer A; Haas CS
J Nephrol; 2017 Jun; 30(3):347-362. PubMed ID: 27848226
[TBL] [Abstract][Full Text] [Related]
29. [Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].
Frémeaux-Bacchi V
Biol Aujourdhui; 2013; 207(4):231-40. PubMed ID: 24594571
[TBL] [Abstract][Full Text] [Related]
30. [Drug/transplant-induced atypical hemolytic uremic syndrome].
Matsui K; Yasuda T
Nihon Jinzo Gakkai Shi; 2014; 56(7):1067-74. PubMed ID: 25420407
[No Abstract] [Full Text] [Related]
31. Living-donor kidney transplantation for atypical haemolytic uremic syndrome with pre-emptive eculizumab use.
Parikova A; Fronek JP; Viklicky O
Transpl Int; 2015 Mar; 28(3):366-9. PubMed ID: 25256057
[No Abstract] [Full Text] [Related]
32. Posttransplant recurrence of atypical hemolytic uremic syndrome.
Valoti E; Alberti M; Noris M
J Nephrol; 2012; 25(6):911-7. PubMed ID: 22760880
[TBL] [Abstract][Full Text] [Related]
33. Hemolytic Uremic Syndrome and Kidney Transplantation: A Case Series and Review of the Literature.
Milan Manani S; Virzì GM; Giuliani A; Clementi A; Brocca A; Dissegna D; Martino F; d''Amore ESG; Ronco C
Nephron; 2017; 136(3):245-253. PubMed ID: 28419995
[TBL] [Abstract][Full Text] [Related]
34. Absence of thrombocytopaenia and/or microangiopathic haemolytic anaemia does not reliably exclude recurrence of atypical haemolytic uraemic syndrome after kidney transplantation.
Krishnan AR; Siva B; Chakera A; Wong G; Wong D; Lim WH
Nephrology (Carlton); 2017 Feb; 22 Suppl 1():28-31. PubMed ID: 28176477
[TBL] [Abstract][Full Text] [Related]
35. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
36. [A case of hemolytic uremic syndrome after cadaveric renal transplantation].
Nagano T; Ikegami M; Matsuda H; Akiyama T; Kurita T
Hinyokika Kiyo; 1996 Jan; 42(1):59-61. PubMed ID: 8686587
[TBL] [Abstract][Full Text] [Related]
37. [The autoimmune thyroiditis with subclinicsal thyreotoxicosis in the immunosupressed patient with renal transplant].
Magomedov AG; Abdulkhalikov AS; Akhmedov IG; Osmanov OM
Khirurgiia (Mosk); 2012; (6):53-4. PubMed ID: 22951616
[No Abstract] [Full Text] [Related]
38. Graft failure due to hemolytic uremic syndrome recurrence.
Iaria G; Iorio B; Anselmo A; De Luca L; Tariciotti L; Ielpo B; Muzi F; Lucchesi C; D'Andria D; Orlando G; Del Poeta G; Poggi E; Piazza A; Tisone G
Transplant Proc; 2006 May; 38(4):1020-1. PubMed ID: 16757250
[TBL] [Abstract][Full Text] [Related]
39. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report.
Ranghino A; Tognarelli G; Basso E; Messina M; Manzione AM; Daidola G; Segoloni GP
Transplant Proc; 2013 Sep; 45(7):2785-7. PubMed ID: 24034049
[TBL] [Abstract][Full Text] [Related]
40. Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report.
Zhu Z; Chen H; Gill R; Wang J; Spitalewitz S; Gotlieb V
J Med Case Rep; 2016 Feb; 10():38. PubMed ID: 26911616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
